Myocardial dysfunction in sepsis: a large, unsolved puzzle
- PMID: 22482045
- PMCID: PMC3312225
- DOI: 10.1155/2012/896430
Myocardial dysfunction in sepsis: a large, unsolved puzzle
Abstract
Sepsis has high incidence and mortality rates around the world. The role of cardiac depression in myocardial dysfunction during sepsis remains to be elucidated. This review attempts to summarize our understanding of the anatomical, histopathological, and pathophysiological mechanisms behind cardiac dysfunction. Biomarkers to detect cardiac depression have been used to recognize developing problems, but the actual impact of these tools remains unclear.
References
-
- the Centers for Disease Control From. Increase in National Hospital Discharge Survey rates for septicemia—United States, 1979–1987. Journal of the American Medical Association. 1990;263(7):937–938. - PubMed
-
- Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. Current epidemiology of septic shock: the CUB-Réa network. American Journal of Respiratory and Critical Care Medicine. 2003;168(2):165–172. - PubMed
-
- Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New England Journal of Medicine. 2001;345(19):1368–1377. - PubMed
-
- Parrillo JE. The cardiovascular pathophysiology of sepsis. Annual Review of Medicine. 1989;40:469–485. - PubMed
LinkOut - more resources
Full Text Sources
